Coeptis Therapeutics Inc (COEP)

[Alinswift]

Updated Info from Company :
the company has sent its form 10 to the company's auditors. Once the company has filed it's form 10, we will update this page and investors page
Capital Structure:
?
After the reverse merger, the Company has 249,038,025 common shares outstanding, 0 shares of Series A Preferred Stock and 2,000,000 shares of Series B Preferred shares. The Series A Preferred were cancelled in 2018 and are no longer outstanding.
?
Common Stock Outstanding: 249,038,025
Common Stock Held At DTC (Cede & Co): 18,074,680
Common Stock Held in Certificate form: 230,963,345
Series A Preferred Outstanding: 0
Series B Preferred Outstanding: 2,000,000